Lin Luo

527 total citations
16 papers, 304 citations indexed

About

Lin Luo is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Lin Luo has authored 16 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Lin Luo's work include Glioma Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (5 papers) and Fibroblast Growth Factor Research (2 papers). Lin Luo is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (5 papers) and Fibroblast Growth Factor Research (2 papers). Lin Luo collaborates with scholars based in China, United States and Italy. Lin Luo's co-authors include Cheng Wei, Lei Han, Zhenyu Zhang, Xiaoyang Zhang, Shenghui Li, Hao Liang, Bo Wang, Fu Zhao, Lei Xu and Lin Ai and has published in prestigious journals such as Frontiers in Immunology, The American Journal of Surgical Pathology and Cell Death and Disease.

In The Last Decade

Lin Luo

16 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Luo China 10 208 118 116 51 31 16 304
Nina Lelic United States 4 184 0.9× 184 1.6× 149 1.3× 46 0.9× 36 1.2× 5 347
Angela Zacher Germany 3 89 0.4× 197 1.7× 119 1.0× 41 0.8× 14 0.5× 3 270
Sandra Ferreyra Vega Sweden 8 111 0.5× 205 1.7× 79 0.7× 48 0.9× 35 1.1× 13 252
Luyan Mu China 12 188 0.9× 107 0.9× 137 1.2× 63 1.2× 35 1.1× 20 383
Katherine Tech United States 6 176 0.8× 115 1.0× 122 1.1× 19 0.4× 11 0.4× 11 308
Lee H. Chen United States 9 234 1.1× 92 0.8× 92 0.8× 39 0.8× 11 0.4× 12 350
Benedicte P. Ulhøi Denmark 6 223 1.1× 93 0.8× 169 1.5× 54 1.1× 15 0.5× 9 321
Haitao Ge China 10 111 0.5× 123 1.0× 95 0.8× 59 1.2× 30 1.0× 23 326
Olivier Saulnier France 6 137 0.7× 168 1.4× 83 0.7× 40 0.8× 17 0.5× 11 273
Erell Guillerm France 9 114 0.5× 82 0.7× 153 1.3× 68 1.3× 31 1.0× 21 351

Countries citing papers authored by Lin Luo

Since Specialization
Citations

This map shows the geographic impact of Lin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Luo more than expected).

Fields of papers citing papers by Lin Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Luo. The network helps show where Lin Luo may publish in the future.

Co-authorship network of co-authors of Lin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Luo. A scholar is included among the top collaborators of Lin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Luo. Lin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Weiyu, Shu Lian, Xiaodong Xie, et al.. (2025). TGF-β secreted by cancer cells-platelets interaction activates cancer metastasis potential by inducing metabolic reprogramming and bioenergetic adaptation. Journal of Cancer. 16(4). 1310–1323. 2 indexed citations
2.
Pei, Dongling, Qimeng Wang, Wenchao Duan, et al.. (2024). Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axis. CNS Neuroscience & Therapeutics. 30(4). e14709–e14709. 5 indexed citations
3.
Luo, Lin, Zhiqi Chen, Chen Xue, et al.. (2023). Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis. Pharmaceuticals. 16(4). 548–548. 5 indexed citations
4.
Zhang, Yibo, Bihui Zhang, He Liu, et al.. (2023). Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist. Journal of Nanobiotechnology. 21(1). 10 indexed citations
5.
Guo, Yang, Zeyu Ma, Dongling Pei, et al.. (2023). Improving Noninvasive Classification of Molecular Subtypes of Adult Gliomas With Diffusion‐Weighted MR Imaging: An Externally Validated Machine Learning Algorithm. Journal of Magnetic Resonance Imaging. 58(4). 1234–1242. 7 indexed citations
6.
7.
Luo, Lin, Yingwei Zhen, Cheng Wei, et al.. (2022). The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer. Cell Death Discovery. 8(1). 325–325. 15 indexed citations
8.
Zhang, Xiaoyang, Ze-Sheng Li, Cheng Wei, et al.. (2022). PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas. Frontiers in Oncology. 12. 1055371–1055371. 10 indexed citations
9.
Luo, Lin, et al.. (2022). CircRNA: An emerging star in the progression of glioma. Biomedicine & Pharmacotherapy. 151. 113150–113150. 28 indexed citations
10.
Wei, Cheng, Bo Wang, Xiaoyang Zhang, et al.. (2022). Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas. Frontiers in Immunology. 13. 849592–849592. 73 indexed citations
11.
Luo, Lin, Xiaoyang Zhang, Yingwei Zhen, et al.. (2022). Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma. Frontiers in Immunology. 13. 1058036–1058036. 5 indexed citations
12.
Wei, Cheng, Xiaoyang Zhang, Xu Zhang, et al.. (2022). LncRNA HOXA11-AS promotes glioma malignant phenotypes and reduces its sensitivity to ROS via Tpl2-MEK1/2-ERK1/2 pathway. Cell Death and Disease. 13(11). 942–942. 23 indexed citations
13.
Zhao, Fu, Zhiwei Zhang, Jing Zhang, et al.. (2021). Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With Medulloblastoma. Frontiers in Oncology. 11. 603686–603686. 4 indexed citations
14.
Zhao, Fu, Tao Wu, Lei‐Ming Wang, et al.. (2021). Survival and Prognostic Factors of Adult Intracranial Ependymoma. The American Journal of Surgical Pathology. 45(7). 979–987. 15 indexed citations
15.
Zhao, Fu, Chunde Li, Bo Wang, et al.. (2017). Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma. Journal of Neuro-Oncology. 135(2). 353–360. 21 indexed citations
16.
Zhao, Fu, Hiroko Ohgaki, Lei Xu, et al.. (2016). Molecular subgroups of adult medulloblastoma: a long-term single-institution study. Neuro-Oncology. 18(7). 982–990. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026